These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30414444)

  • 1. Structural studies and biological evaluation of T30695 variants modified with single chiral glycerol-T reveal the importance of LEDGF/p75 for the aptamer anti-HIV-integrase activities.
    Rivieccio E; Tartaglione L; Esposito V; Dell'Aversano C; Koneru PC; Scuotto M; Virgilio A; Mayol L; Kvaratskhelia M; Varra M
    Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):351-361. PubMed ID: 30414444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the Importance of the G-Quadruplex Grooves for the Activity of the Anti-HIV-Integrase Aptamer T30923.
    Esposito V; Esposito F; Pepe A; Gomez Monterrey I; Tramontano E; Mayol L; Virgilio A; Galeone A
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops.
    Virgilio A; Amato T; Petraccone L; Esposito F; Grandi N; Tramontano E; Romero R; Haider S; Gomez-Monterrey I; Novellino E; Mayol L; Esposito V; Galeone A
    Sci Rep; 2018 May; 8(1):7447. PubMed ID: 29749406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the binding of d(GGGT)4 to the HIV-1 integrase: An approach to investigate G-quadruplex aptamer/target protein interactions.
    Esposito V; Pirone L; Mayol L; Pedone E; Virgilio A; Galeone A
    Biochimie; 2016 Aug; 127():19-22. PubMed ID: 27109379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.
    Feng L; Dharmarajan V; Serrao E; Hoyte A; Larue RC; Slaughter A; Sharma A; Plumb MR; Kessl JJ; Fuchs JR; Bushman FD; Engelman AN; Griffin PR; Kvaratskhelia M
    ACS Chem Biol; 2016 May; 11(5):1313-21. PubMed ID: 26910179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity of tetrad-forming oligonucleotides as a potent anti-HIV therapeutic drug.
    Jing N; Hogan ME
    J Biol Chem; 1998 Dec; 273(52):34992-9. PubMed ID: 9857031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. d(GGGT) 4 and r(GGGU) 4 are both HIV-1 inhibitors and interleukin-6 receptor aptamers.
    Magbanua E; Zivkovic T; Hansen B; Beschorner N; Meyer C; Lorenzen I; Grötzinger J; Hauber J; Torda AE; Mayer G; Rose-John S; Hahn U
    RNA Biol; 2013 Feb; 10(2):216-27. PubMed ID: 23235494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design.
    Jing N; De Clercq E; Rando RF; Pallansch L; Lackman-Smith C; Lee S; Hogan ME
    J Biol Chem; 2000 Feb; 275(5):3421-30. PubMed ID: 10652335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stacking of G-quadruplexes: NMR structure of a G-rich oligonucleotide with potential anti-HIV and anticancer activity.
    Do NQ; Lim KW; Teo MH; Heddi B; Phan AT
    Nucleic Acids Res; 2011 Nov; 39(21):9448-57. PubMed ID: 21840903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75.
    Zhang DW; Yan HL; Xu XS; Xu L; Yin ZH; Chang S; Luo H
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):906-912. PubMed ID: 32228103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the potent inhibition of the HIV integrase-LEDGF/p75 protein-protein interaction.
    Ribone SR; Quevedo MA
    J Mol Graph Model; 2017 Aug; 75():189-198. PubMed ID: 28582696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.
    Xue W; Liu H; Yao X
    PLoS One; 2014; 9(3):e90799. PubMed ID: 24599328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
    De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
    ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity.
    Amadori C; van der Velden YU; Bonnard D; Orlov I; van Bel N; Le Rouzic E; Miralles L; Brias J; Chevreuil F; Spehner D; Chasset S; Ledoussal B; Mayr L; Moreau F; García F; Gatell J; Zamborlini A; Emiliani S; Ruff M; Klaholz BP; Moog C; Berkhout B; Plana M; Benarous R
    Retrovirology; 2017 Nov; 14(1):50. PubMed ID: 29121950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in the Development of Small-Molecular Inhibitors Target HIV Integrase-LEDGF/p75 Interaction.
    Zhao Y; Luo Z
    Mini Rev Med Chem; 2015; 15(14):1195-208. PubMed ID: 26156421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the interactions between HIV-1 integrase and human LEDGF/p75 by molecular dynamics simulation and free energy calculation.
    Zhao Y; Li W; Zeng J; Liu G; Tang Y
    Proteins; 2008 Aug; 72(2):635-45. PubMed ID: 18247352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.
    Al-Mawsawi LQ; Christ F; Dayam R; Debyser Z; Neamati N
    FEBS Lett; 2008 Apr; 582(10):1425-30. PubMed ID: 18331842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,2,3,4-Tetrahydroisoquinolines as inhibitors of HIV-1 integrase and human LEDGF/p75 interaction.
    George A; Gopi Krishna Reddy A; Satyanarayana G; Raghavendra NK
    Chem Biol Drug Des; 2018 Jun; 91(6):1133-1140. PubMed ID: 29405651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment hopping approach directed at design of HIV IN-LEDGF/p75 interaction inhibitors.
    De Luca L; Ferro S; Morreale F; Christ F; Debyser Z; Chimirri A; Gitto R
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1002-9. PubMed ID: 22803661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectroscopic Properties of Two 5'-(4-Dimethylamino)Azobenzene Conjugated G-Quadruplex Forming Oligonucleotides.
    Imperatore C; Varriale A; Rivieccio E; Pennacchio A; Staiano M; D'Auria S; Casertano M; Altucci C; Valadan M; Singh M; Menna M; Varra M
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.